Funding has been created to support Integrated Care Systems (ICSs) who have an active interest in introducing or scaling up digital innovations within their gastroenterology pathway and have already done some thinking in this area.
Building on the recent launch of the Gastroenterology digital playbook, £1m worth of funding is available for ICSs to purchase and implement technology. Applicants can apply for up to £200,000 to support the testing and implementation of evidence-based technologies along the gastroenterology pathway which support sustainable pathway redesign.
Applications from interested ICSs can be submitted between 12 August to 17 September 2021.
Get involved and submit your application
The application form for the opportunity to receive gastroenterology funding is available as a document that you can download and complete (ODT, 85 KB).
Once completed all forms must be returned by email to email@example.com by 17 September 2021 and include "Gastroenterology - Adoption Fund Application (insert your ICS name)" in the subject line.
If you have any queries prior to submission, please email firstname.lastname@example.org and include the same process as above in the subject line.
Please ensure you have read the guidance criteria below to help prepare your application.
Guidance to support applications
Prerequisites to applying for funding
Applications from ICSs who have an active interest in introducing or scaling up digital innovations within their gastroenterology pathway and have already done some thinking in this area.
We are looking for ICSs to pilot one or both from the following already identified areas of interest:
Home testing for Faecal Calprotectin
Projects to establish cost-effectiveness and demonstrate embedding of patient self-testing in IBD management pathways. To support the digital transformation of outpatient care for IBD and (ideally) introduce elements of PIFU.
Bowel Prep Patient Education
Using or developing educational materials to support patients who need bowel prep at home before a colonoscopy - including a model for automating patient SMS reminders (inter-operable) to upscale their timely utilisation by patients.
A total of £1m worth of funding is available for ICSs to purchase and implement technology.
ICSs can apply for up to £200,000 each to support the testing and implementation of evidence-based technologies along the gastroenterology pathway which support sustainable pathway redesign.
Expectations of the ICSs
Each ICS would be:
- offered funding (up to £200,000 for home testing for faecal calprotectin and up to £100,000 for bowel prep patient education) to purchase and implement technology. The maximum ward for any ICS is £200,000.
- invited to join a community of digital innovators in gastroenterology, to discuss and share learning and resources online every 4 to 6 weeks (frequency to be agreed)
- Will be asked to submit data returns on numbers of patients on new pathways and benefits related to this e.g. reduction in numbers of patients failing bowel prep and impact of new faecal calprotectin tests on IBD pathway
- expected to produce a case study at the end of the project, share useful resources via FutureNHS and take part in show and tell events to share learning as appropriate
ICSs will be required to have live pathways to work on and the internal resource, commitment and desire to implement technology by early 2022.
Applications to be submitted by ICSs need to show active engagement from ICS partners, senior level buy-in and be willing to share learning with others.
ICSs will have live pathways to work on and the internal resource, commitment and desire to implement technology by early 2022.
There are seven sections to complete, below is the scoring criteria.
|Section||% of total score||Scoring criteria|
|Contact details||5%||All required contact information is present. The project has a Senior Responsible Officer and Finance approver. All lists of all participating organisations are given.|
|Funding requested||10%||Funding request is within the limit. A breakdown of how the funding is to be used is provided. No requested funding items are out of scope.|
|Summary of proposal||20%||It is clear what the project is wanting to do and why; there are clear benefits and an approach for evaluating these is offered; there is clear learning for others across the community.|
|Which outcomes will the proposal meet?||20%||The project demonstrates clear alignment to regional / national priorities. It is clear the project considers a whole pathway redesign approach which aligns with national priorities.|
|The technology||15%||The technology identified appears to solve a real-world problem in the cancer pathway. Funding requested / spent represents value for money. A clear plan for commissioning / procurement and evaluation is presented.|
|Sustainability; local priorities; governance and conditions of participation||20%||Clear and robust governance arrangements are presented. Local relationships are in place OR there is a clear plan to engage with these organisations / people. All conditions for participation are met.|
|Risks,issues and mitigations||10%||Key risks to delivery have been identified and mitigated.|
All applicants need to ensure that submissions are registered for consideration in line with the deadline dates set out below.
- Application process opens on 12 August
- Information webinars to be held on 7 September, 10-11 am - please email email@example.com for more information
- Application process closes on 17 September
- Shortlisted applicants notified on 1 October
- Final decision made and successful applicants informed on 8 October
- All funding spent
- Case study produced (or in the process of of being drafted)